Related Experiment Videos
Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7.
L S Taams1, L W Poulter, M H Rustin
1Department of Clinical Immunology, Royal Free and University College Medical School, London, UK.
Summary
Interleukin-10 (IL-10) induces suppressive antigen-presenting cells (APCs) by reducing RFD1 and HLA class II expression, while increasing RFD7. Interferon-gamma (IFNγ) promotes inductive APCs.
Area of Science:
- Immunology
- Cell Biology
Background:
- Tolerogenic antigen-presenting cells (APCs) are crucial for controlling immune responses and preventing autoimmunity.
- Interleukin-10 (IL-10) and anergic T cells are implicated in inducing these suppressive APCs.
Purpose of the Study:
- To investigate the mechanisms by which IL-10 and anergic T cells induce a suppressive APC phenotype.
- To understand how this induced phenotype impacts the overall immune response.
Main Methods:
- Macrophages were differentiated from peripheral blood mononuclear cells.
- Cultures were treated with IL-10 or Interferon-gamma (IFNγ).
- Phenotypic analysis was performed using immunohistochemical staining and Fluorescence-activated cell sorting (FACS) with RFD1 and RFD7 monoclonal antibodies.
Main Results:
- IL-10 treatment reduced RFD1 staining and HLA class II expression while increasing RFD7 staining.
- IFNγ treatment upregulated RFD1 and HLA class II expression without affecting RFD7 staining.
- These findings suggest IL-10 induces a suppressive RFD1+RFD7+ APC phenotype, whereas IFNγ induces an inductive RFD1+RFD7- APC subset.
Conclusions:
- IL-10 and IFNγ differentially modulate APC phenotypes, distinguishing between suppressive and inductive states.
- Monoclonal antibodies RFD1 and RFD7 are valuable tools for assessing APC function and T cell anergy.
- This model provides a framework for studying APCs in the context of immune regulation and tolerance.